Sign in
4

Changes in Ownership

Arbutus Biopharma Corp Filed Acc 0001144204-17-052970

Options or other derivatives

  • 10% owner bought 500,000 shares at $100.00 ($50,000,000)

From the SEC's structured data for this filing

Trades in this filing

Dexxon Holdings Ltd. · 10% owner

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2017-10-16 Purchase : show line 1 in the form Series A Participating Convertible Preferred Shares +500,000 $100.00 $50,000,000 500,000 I
Loading xslF345X03/tv476968_4.xml…